NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be nor more than 48 months. Please refer to the offer documents for the list of purchasing points.
- Procurement
- Hereditary Angioedema
- Buyer
- NHS England
- Published
- 9 Feb 2022
- Status
- active
- CPV
- 33600000 — Pharmaceutical products
- Tender period
- — – 16 Mar 2022
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a tender notice published via Contracts Finder on 9 Feb 2022.
Which procurement does this notice belong to?
It is part of "Hereditary Angioedema", published by NHS England.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable